Lista de obras - Maria Chiara Zatelli - Dominio Público Uruguay

A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization ⬇️

artículo científico publicado el 1 de noviembre de 2010

A tool to predict survival in stage IV entero-pancreatic NEN

artículo científico publicado en 2020

Acromegaly in the elderly patients

artículo científico publicado en 2020

Acromegaly secondary to an incidentally discovered growth-hormone-releasing hormone secreting bronchial carcinoid tumour associated to a pituitary incidentaloma

artículo científico publicado en 2008

Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone-releasing hormone

artículo científico publicado en 2003

An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro

artículo científico publicado en 2003

Androgen influences transforming growth factor-beta1 gene expression in human adrenocortical cells

artículo científico publicado en 2000

Anterior Pituitary Function May Predict Functional and Cognitive Outcome in Patients with Traumatic Brain Injury Undergoing Rehabilitation

artículo científico publicado en 2007

Antiproliferative effects of somatostatin analogs in pituitary adenomas

artículo científico publicado en 2006

BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies.

artículo científico publicado en 2009

BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present

artículo científico publicado en 2013

Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion

artículo científico publicado en 2013

Cardiac and metabolic effects of chronic growth hormone and insulin-like growth factor I excess in young adults with pituitary gigantism

artículo científico publicado en 2005

Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study

article

Clinical Value of Different Responses of Serum Thyroglobulin to Recombinant Human Thyrotropin in the Follow-Up of Patients with Differentiated Thyroid Carcinoma

article

Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma

artículo científico publicado en 2005

Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds

artículo científico publicado en 2007

Corticotropin releasing hormone: a diagnostic marker for behavioral and reproductive disorders?

artículo científico publicado en 2007

Cyclo-oxygenase 2 modulates chemoresistance in breast cancer cells involving NF-kappaB.

artículo científico publicado en 2009

Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression

artículo científico publicado en 2007

Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism

artículo científico publicado en 2005

Deletion of exons 1–3 of the MEN1 gene in a large Italian family causes the loss of menin expression

article

Detection of antipituitary and antihypothalamus antibodies to investigate the role of pituitary or hypothalamic autoimmunity in patients with selective idiopathic hypopituitarism

scientific article published on 01 September 2011

Dopamine receptor subtype 2 and somatostatin receptor subtype 5 expression influences somatostatin analogs effects on human somatotroph pituitary adenomas in vitro.

artículo científico publicado en 2005

Dual-energy X-ray absorptiometry pitfalls in Thalassemia Major

scientific article published on 12 July 2019

Effect of everolimus on cell viability in nonfunctioning pituitary adenomas.

artículo científico publicado en 2009

Evaluation of hormonal function in a series of incidentally discovered adrenal masses.

artículo científico publicado en 1997

Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids.

artículo científico publicado en 2010

Evidence for Differential Effects of Selective Somatostatin Receptor Subtype Agonists on α-Subunit and Chromogranin A Secretion and on Cell Viability in Human Nonfunctioning Pituitary Adenomasin Vitro

artículo científico publicado en 2004

Evidence for integrity of the growth hormone/insulin-like growth factor-1 axis in patients with severe head trauma during rehabilitation

artículo científico publicado en 2002

Expression of functional KISS1 and KISS1R system is altered in human pituitary adenomas: evidence for apoptotic action of kisspeptin-10

artículo científico publicado en 2010

Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation

artículo científico publicado en 2014

Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines

artículo científico publicado en 2016

Growth hormone excess promotes breast cancer chemoresistance

artículo científico publicado en 2009

Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression

artículo científico publicado en 2012

Growth hormone values after an oral glucose load do not add clinically useful information in patients with acromegaly on long-term somatostatin receptor ligand treatment

artículo científico publicado en 2013

Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients

artículo científico publicado en 2012

Hypeprolactinemia: still an insidious diagnosis

scientific article published on 19 September 2020

Hypopituitarism after traumatic brain injury

artículo científico publicado en 2005

Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas

artículo científico publicado en 2007

Igf-I influences everolimus activity in medullary thyroid carcinoma

artículo científico publicado en 2015

In vitro testing of new somatostatin analogs on pituitary tumor cells

artículo científico publicado en 2007

Inhibitory effects of mitotane on viability and secretory activity in mouse gonadotroph cell lines

artículo científico publicado en 2014

Isolated R171Q amino acid change in MEN1 gene: polymorphism or mutation?

artículo científico publicado en 2008

Levels of p27 sensitize to dual PI3K/mTOR inhibition

artículo científico publicado en 2011

Magmas overexpression inhibits staurosporine induced apoptosis in rat pituitary adenoma cell lines

artículo científico publicado en 2013

Magmas, a gene newly identified as overexpressed in human and mouse ACTH-secreting pituitary adenomas, protects pituitary cells from apoptotic stimuli

scientific journal article

Metabolic and anatomic characteristics of benign and malignant adrenal masses on positron emission tomography/computed tomography: a review of literature

artículo científico

MicroRNAs and possible role in pituitary adenoma.

artículo científico publicado en 2008

Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells

artículo científico publicado en 2014

Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function

artículo científico publicado en 2013

Molecular basis of pharmacological therapy in Cushing's disease

artículo científico publicado en 2013

Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes

artículo científico publicado en 2010

Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes

scholarly article by Cristina Romei et al published December 2010 in European Journal of Endocrinology

N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis

artículo científico publicado en 2014

Occurrence of pituitary dysfunction following traumatic brain injury

artículo científico publicado en 2004

Ovarian tumors secreting insulin

artículo científico publicado en 2015

PI3K/Akt/mTOR pathway involvement in regulating growth hormone secretion in a rat pituitary adenoma cell line.

artículo científico publicado en 2017

Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion

scientific article published on 01 March 2007

Pathogenesis of non-functioning pituitary adenomas

artículo científico publicado en 2018

Pituitary side effects of old and new drugs

artículo científico publicado en 2014

Predictive value of circulating insulin-like growth factor I levels in ischemic stroke outcome

artículo científico publicado en 2006

Predictors of pituitary dysfunction in patients surviving ischemic stroke

artículo científico publicado en 2010

Prognostic Significance of the Ki-67 Labeling Index in Growth Hormone-Secreting Pituitary Adenomas

artículo científico publicado en 2008

Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses.

artículo científico publicado en 2016

Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines

artículo científico publicado en 2007

Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells

artículo científico publicado en 2015

Protein kinase C: a putative new target for the control of human medullary thyroid carcinoma cell proliferation in vitro

artículo científico publicado en 2012

RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease.

artículo científico publicado en 2002

Radio-guided selective compartment neck dissection improves staging in papillary thyroid carcinoma: a prospective study on 345 patients with a 3-year follow-up.

artículo científico publicado en 2014

Rare diseases in clinical endocrinology: a taxonomic classification system.

artículo científico publicado en 2014

Real-world study of everolimus in advanced progressive neuroendocrine tumors

artículo científico publicado en 2014

Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer

artículo científico publicado en 2014

Risk factors for development of atypical femoral fractures in patients on long-term oral bisphosphonate therapy

artículo científico publicado en 2013

Role of complex cyclin d1/cdk4 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro.

artículo científico publicado en 2006

Role of pituitary tumour transforming gene 1 in medullary thyroid carcinoma

artículo científico publicado en 2010

Role of transforming growth factor beta 1 (TGF beta 1) in mediating androgen-induced growth inhibition in human adrenal cortex in vitro

artículo científico publicado en 1998

Role of ultrasonographic/clinical profile, cytology, and BRAF V600E mutation evaluation in thyroid nodule screening for malignancy: a prospective study

artículo científico publicado en 2012

Runx2 mRNA expression in the tissue, serum, and circulating non-hematopoietic cells of patients with thyroid cancer

artículo científico publicado en 2012

SPECT- and PET-based patient-tailored treatment in neuroendocrine tumors: a comprehensive multidisciplinary team approach.

artículo científico publicado en 2015

SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma.

artículo científico publicado en 2005

Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives.

artículo científico publicado en 2006

Should aip gene screening be recommended in family members of FIPA patients with R16H variant?

artículo científico publicado en 2013

Somatostatin analogs in vitro effects in a growth hormone-releasing hormone-secreting bronchial carcinoid

artículo científico publicado en 2005

Somatostatin receptor subtype 1-selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line

artículo científico publicado en 2002

Somatostatin receptors: from basic science to clinical approach--thyroid.

artículo científico publicado en 2004

Somatostatin, but not somatostatin receptor subtypes 2 and 5 selective agonists, inhibits calcitonin secretion and gene expression in the human medullary thyroid carcinoma cell line, TT.

artículo científico publicado en 2002

Systemic illness

artículo científico publicado en 2008

Targeting protein kinase C by Enzastaurin restrains proliferation and secretion in human pancreatic endocrine tumors.

artículo científico publicado en 2011

The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells

artículo científico publicado en 2015

Therapeutic concentrations of mitotane (o,p'-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model

artículo científico publicado en 2010

Unexpected activation of pituitary-adrenal axis in healthy young and elderly subjects during somatostatin infusion

artículo científico publicado en 1998

Utilization of luminescent technology to develop a kinase assay: Cdk4 as a model system

artículo científico publicado en 2005

Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto's thyroiditis

artículo científico publicado en 2012

mTOR, p70S6K, AKT, and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids.

artículo científico publicado en 2013

miR-15a and miR-16-1 down-regulation in pituitary adenomas

artículo científico publicado en 2005

miR-26a plays an important role in cell cycle regulation in ACTH-secreting pituitary adenomas by modulating protein kinase Cδ.

artículo científico publicado en 2013

Lista de obras de Maria Chiara Zatelli

A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization ⬇️

A tool to predict survival in stage IV entero-pancreatic NEN

Acromegaly in the elderly patients

Acromegaly secondary to an incidentally discovered growth-hormone-releasing hormone secreting bronchial carcinoid tumour associated to a pituitary incidentaloma

Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone-releasing hormone

An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro

Androgen influences transforming growth factor-beta1 gene expression in human adrenocortical cells

Anterior Pituitary Function May Predict Functional and Cognitive Outcome in Patients with Traumatic Brain Injury Undergoing Rehabilitation

Antiproliferative effects of somatostatin analogs in pituitary adenomas

BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies.

BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present

Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion

Cardiac and metabolic effects of chronic growth hormone and insulin-like growth factor I excess in young adults with pituitary gigantism

Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study

Clinical Value of Different Responses of Serum Thyroglobulin to Recombinant Human Thyrotropin in the Follow-Up of Patients with Differentiated Thyroid Carcinoma

Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma

Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds

Corticotropin releasing hormone: a diagnostic marker for behavioral and reproductive disorders?

Cyclo-oxygenase 2 modulates chemoresistance in breast cancer cells involving NF-kappaB.

Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression

Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism

Deletion of exons 1–3 of the MEN1 gene in a large Italian family causes the loss of menin expression

Detection of antipituitary and antihypothalamus antibodies to investigate the role of pituitary or hypothalamic autoimmunity in patients with selective idiopathic hypopituitarism

Dopamine receptor subtype 2 and somatostatin receptor subtype 5 expression influences somatostatin analogs effects on human somatotroph pituitary adenomas in vitro.

Dual-energy X-ray absorptiometry pitfalls in Thalassemia Major

Effect of everolimus on cell viability in nonfunctioning pituitary adenomas.

Evaluation of hormonal function in a series of incidentally discovered adrenal masses.

Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids.

Evidence for Differential Effects of Selective Somatostatin Receptor Subtype Agonists on α-Subunit and Chromogranin A Secretion and on Cell Viability in Human Nonfunctioning Pituitary Adenomasin Vitro

Evidence for integrity of the growth hormone/insulin-like growth factor-1 axis in patients with severe head trauma during rehabilitation

Expression of functional KISS1 and KISS1R system is altered in human pituitary adenomas: evidence for apoptotic action of kisspeptin-10

Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation

Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines

Growth hormone excess promotes breast cancer chemoresistance

Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression

Growth hormone values after an oral glucose load do not add clinically useful information in patients with acromegaly on long-term somatostatin receptor ligand treatment

Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients

Hypeprolactinemia: still an insidious diagnosis

Hypopituitarism after traumatic brain injury

Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas

Igf-I influences everolimus activity in medullary thyroid carcinoma

In vitro testing of new somatostatin analogs on pituitary tumor cells

Inhibitory effects of mitotane on viability and secretory activity in mouse gonadotroph cell lines

Isolated R171Q amino acid change in MEN1 gene: polymorphism or mutation?

Levels of p27 sensitize to dual PI3K/mTOR inhibition

Magmas overexpression inhibits staurosporine induced apoptosis in rat pituitary adenoma cell lines

Magmas, a gene newly identified as overexpressed in human and mouse ACTH-secreting pituitary adenomas, protects pituitary cells from apoptotic stimuli

Metabolic and anatomic characteristics of benign and malignant adrenal masses on positron emission tomography/computed tomography: a review of literature

MicroRNAs and possible role in pituitary adenoma.

Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells

Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function

Molecular basis of pharmacological therapy in Cushing's disease

Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes

Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes

N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis

Occurrence of pituitary dysfunction following traumatic brain injury

Ovarian tumors secreting insulin

PI3K/Akt/mTOR pathway involvement in regulating growth hormone secretion in a rat pituitary adenoma cell line.

Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion

Pathogenesis of non-functioning pituitary adenomas

Pituitary side effects of old and new drugs

Predictive value of circulating insulin-like growth factor I levels in ischemic stroke outcome

Predictors of pituitary dysfunction in patients surviving ischemic stroke

Prognostic Significance of the Ki-67 Labeling Index in Growth Hormone-Secreting Pituitary Adenomas

Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses.

Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines

Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells

Protein kinase C: a putative new target for the control of human medullary thyroid carcinoma cell proliferation in vitro

RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease.

Radio-guided selective compartment neck dissection improves staging in papillary thyroid carcinoma: a prospective study on 345 patients with a 3-year follow-up.

Rare diseases in clinical endocrinology: a taxonomic classification system.

Real-world study of everolimus in advanced progressive neuroendocrine tumors

Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer

Risk factors for development of atypical femoral fractures in patients on long-term oral bisphosphonate therapy

Role of complex cyclin d1/cdk4 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro.

Role of pituitary tumour transforming gene 1 in medullary thyroid carcinoma

Role of transforming growth factor beta 1 (TGF beta 1) in mediating androgen-induced growth inhibition in human adrenal cortex in vitro

Role of ultrasonographic/clinical profile, cytology, and BRAF V600E mutation evaluation in thyroid nodule screening for malignancy: a prospective study

Runx2 mRNA expression in the tissue, serum, and circulating non-hematopoietic cells of patients with thyroid cancer